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ABSTRACT
Introduction Evidence regarding effective communication 
between clinicians and patients with inflammatory bowel 
disease (IBD) is limited. Studies that investigate clinical 
communication in IBD are much fewer in number than 
studies that investigate the perceptions of patients and 
clinicians about communication in clinical encounters. The 
current review aims to identify, organise and summarise 
systematically what is currently known about (1) the 
characteristics of interactions between clinicians who 
manage IBD and patients with IBD, and (2) how clinical 
discussion affects health outcomes in IBD.
Methods and analysis Scopus, PubMed, Embase, 
Communication Abstracts, Health & Society, Linguistics 
and Language Behavior Abstracts and PsycINFO will be 
systematically searched for studies that investigate the 
characteristics of IBD clinical interactions during recorded 
consultations, from earliest available dates within each 
database to May 2020. A specifically developed quality 
assessment tool, grounded in linguistic theory, will be 
used to critically assess the evidence. In addition, a data 
extraction template will be developed and utilised to 
provide a description of the characteristics of IBD clinical 
communication as well as an estimation of its effect on 
health outcomes in a narrative synthesis.
Ethics and dissemination Ethical review and approval is 
not required for this systematic review as no primary data 
will be collected. The results will be published in peer- 
reviewed journals and presented at academic conferences.
PROSPERO registration number International 
Prospective Register of Systematic Reviews (PROSPERO) 
on 28 April 2020 (registration number: CRD42020169657).
INTRODUCTION
Inflammatory bowel disease (IBD) is a 
chronic inflammatory condition of the 
gastrointestinal tract mainly presenting in two 
forms: Crohn’s disease (CD) and ulcerative 
colitis (UC). IBD is characterised by inter-
mittent periods of active disease with symp-
toms including diarrhoea, rectal bleeding, 
urgency, incontinence, chronic abdominal 
pain, loss of appetite and weight loss, fatigue, 
joint pain and skin problems that undermine 
patients’ quality of life and emotional well- 
being which can affect their personal, social 
and professional life. The incidence of IBD 
is highest among those aged between 15 and 
29 years,1 exacerbating the economic burden 
of the disease due to effects on the ability 
to work of the large young population of 
patients with IBD.
Due to the chronicity of IBD, patients 
require ongoing monitoring and long- term 
maintenance therapy to stay in remission and 
prevent recurrence of disease activity. Treat-
ment of IBD has become more effective over 
time due to advances in medical and clinical 
research and the introduction of more effec-
tive drugs. At the same time, it has become 
more complicated because of the complex 
risk–benefit profile of the more effective 
treatments. As a result, discourses around 
the role of the patient as a key stakeholder 
in decision- making have found more recog-
nition and prominence in IBD research.2 3 
Since the main space in which clinicians and 
patients negotiate roles and make decisions is 
their clinical interaction during consultations, 
Strengths and limitations of this study
 ► This systematic review will be the very first to 
identify, assess and summarise evidence resulting 
from investigations of recorded clinical interactions 
during IBD consultations.
 ► The review will consult a diverse range of data-
bases—including databases with special focus on 
medicine, health, psychology, communication and 
linguistics— to identify eligible studies.
 ► The review will use a specifically developed quality 
assessment tool, grounded in linguistic theory, to 
critically assess the evidence.
 ► It is expected that the findings will not be integrated 
to produce cumulative evidence due to the antici-
pated diverse range of included studies in terms of 
context and theoretical underpinnings.
 ► Due to funding limitations, this systematic review 
will be restricted to publications in English language 
only and, thus, may not represent all the available 
evidence.
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understanding the exchange of meaning between clini-
cians and patients in this space and its existing variations 
is crucial for understanding the bigger picture of how—
and how well—IBD is managed. Such an understanding 
can help identify ways in which IBD care can improve.
Effects of clinical communication on health outcomes 
include patient satisfaction, adherence, patient quality 
of life, disease management and self- management, as 
discussed by a number of studies in the IBD- specific liter-
ature and by many more studies concerned with other 
conditions. Ghosh and colleagues argued that in IBD, 
‘good communication between physician and patient 
is a cornerstone of effective disease management’4 (p 
S245). The authors suggested that motivational commu-
nication may be valuable in IBD care, ‘where the use of 
treatments with potentially undesirable side effects must 
be balanced against the risk of life- long high morbidity 
from the disease’4 (p S247). Motivational communication 
is a collaborative approach used to elicit the person’s own 
intrinsic motivation and resources for change.5 A survey 
study by Mocciaro and colleagues showed that motiva-
tional communication in IBD consultations improved 
patient satisfaction, and potentially medication adher-
ence and smoking cessation and helped physicians in 
dealing with patients ‘moving from ‘cure’ to ‘care’’.6
Highlighting the link between clinical communica-
tion and patient quality of life and disease management, 
Mitchell and colleagues argued that discussing the 
impact of IBD on a patient’s daily life during a consul-
tation can produce a better ‘picture of how patients are 
affected by their disease and how well their current treat-
ment strategy is working for them’7 (p2), and provides 
a context for considering new treatment options based 
on patients’ expectations of treatment, ability to adapt 
and treatment objectives. Furthermore, Kennedy and 
colleagues pointed out the impact of effective commu-
nication on ‘encouraging and supporting decisions and 
self- care actions which may enable patients to optimally 
manage their condition outside of health service settings’8 
(p567–8).
While there has been advocacy for research on commu-
nication in IBD, projects whose ‘site of engagement/
intervention’ is the ‘clinician–patient interface’9—that is, 
projects that investigate interactions between patients and 
clinicians, rather than patients’ perceptions of clinical 
communication—are less known. No systematic literature 
review has been conducted to identify and review such 
studies. In 2004, Husain and Triadafilopoulos pointed to 
‘a paucity of data concerning effective communication 
methods enabling physicians to develop stronger rapport 
with patients suffering from IBD’10 (p444). Sixteen years 
later, we still do not know much about the status of IBD 
communication from research that uses real- life clini-
cian–patient conversation data. The current review aims 
to ascertain the existing knowledge in this area to inform 
the field, identify the gaps and areas that require further 
investigations, and position this literature within current 
IBD care practice and research. The main objective is to 
identify, organise and summarise systematically what is 
currently known about (1) the characteristics of conver-
sations between clinicians who manage IBD and patients 
with IBD, and (2) how clinical discussion affects health 
outcomes in IBD.
METHODS
The development of this study protocol was in accordance 
to the Preferred Reporting Items for Systematic Review 
and Meta- Analysis Protocols (PRISMA- P).11 12 A copy of 
the completed PRISMA- P 2015 checklist is presented in 
online supplemental appendix 1. This study protocol 
is registered with the International Registration of 
Systematic reviews (PROSPERO, registration number: 
CRD42020169657).
Eligibility criteria
The review will include studies that investigate the charac-
teristics of the interactions between clinicians who manage 
patients with IBD and/or their parent/guardian during 
a recorded consultation. These characteristics generally 
include, but are not limited to, the content of the consul-
tation, patients’ and clinicians’ experience as represented 
in their language, the interpersonal meanings exchanged 
in the consultation, the different rhetorical steps that 
make up the consultation and the flow of information 
in the consultation. Studies based only on self- report of 
interaction for example, focus group studies, interviews, 
surveys or participatory observation with no audio/video 
recording will be excluded.
Published peer- reviewed studies in English that used 
quantitative or qualitative methods (including, but not 
limited to, discourse analysis, conversation analysis and 
content analysis) to analyse recorded real- life interac-
tions between clinicians and patients with IBD (UC or 
CD) during a consultation will be included in the review. 
Eligible studies will need to sample patients with IBD 
and clinicians who manage patients with IBD in primary 
and secondary healthcare (eg, general practitioners, 
IBD specialists, IBD nurses), complementary medicine 
(eg, acupuncturists, traditional Chinese medicine prac-
titioner) or allied health (eg, dietitian). Studies with a 
focus on healthcare providers whose primary treatment 
includes the interaction itself (eg, psychotherapists) will 
be excluded. Studies in which these participant groups 
are present but IBD is not the focus of the study will also 
be excluded. Studies will be selected regardless of the 
type of intervention or exposure as the review will not 
be focused on a certain type of intervention or exposure. 
Only journal articles and book chapters published in 
English are eligible. Peer- reviewed published abstracts, 
letters to the editor, editorials and theses will be excluded. 
However, ineligible sources will be examined to locate 
corresponding journal articles. Articles published up to 
May 2020 will be included.
Information sources and search strategy
The review will search for records indexed in:
1. Scopus
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2. PubMed
3. Embase
4. Communication Abstracts
5. Health & Society
6. Linguistics and Language Behavior Abstracts
7. PsycINFO
In addition, snowball sampling will be employed. 
Reference lists of eligible articles identified in the online 
database search as well as the excluded but relevant 
publications will be consulted. Subject matter experts 
(those known to the researchers as well as those identi-
fied in the database search and snowball sampling) will 
be contacted via email and consulted to identify any addi-
tional literature.
A relatively broad search strategy will be employed due 
to anticipating limited numbers of studies that explore 
real- life clinician–patient interactions in IBD and in order 
to maximise the reach. Table 1 lists the keywords that will 
be used to search these databases. Keywords referring to 
the condition or healthcare domain being studied (eg, 
IBD) will be used; in conjunction with terms describing 
the data type (eg, consultation and audio- record*). The 
search strategy will represent the intersection of these two 
sets of terms.
Data management and selection process
Study records obtained from the databases will be 
exported into Endnote where duplicates will be removed, 
and screening of titles and abstracts and then full- text 
records will be performed independently by three 
reviewers (NK, RK and AL). The reviewers will be overin-
clusive with their selections and will include all the studies 
that appear to meet the inclusion criteria as well as those 
whose eligibility for inclusion is uncertain. Reviewers will 
not be blinded to the study authors, institutions or jour-
nals of the records they screen.
Once the reviewers complete the screening of titles and 
abstracts, they will meet to compare their lists of selected 
studies and resolve any discrepancies prior to the full- text 
review. Any unresolved disagreement will be discussed 
with the whole review team and a collective decision will 
be made. Reasons for exclusion will also be recorded at 
this stage. Once agreement is reached, the full text of the 
selected studies will be uploaded in Endnote and studied 
independently by the reviewers for final inclusions. The 
same discrepancy resolving process will be repeated 
at this final stage of selection. Reviewers will meet on 
finishing the independent selection process to resolve 
any disagreements and will discuss matters with the whole 
review team if they cannot reach an agreement.
Data collection and extraction processes
Selected articles will be carefully studied by the whole 
team. A data extraction template will be developed based 
on the questions asked in the review and the informa-
tion available in the selected studies, and in consultation 
with the existing health communication and linguistics 
literature including previous systematic literature reviews 
of this kind9 13–16 and Halliday’s theoretical model of 
the architecture of language, known as systemic func-
tional linguistics.17 The data extraction template will be 
accompanied by detailed instructions in Microsoft Excel 
(2007). It will be piloted by two reviewers on a sample of 
included papers to ensure the efficiency of the template 
and the accuracy and consistency of extractors before the 
final data extraction which will be performed by NK and 
checked by the review team.
The review will explore potential trends in this strand 
of research by comparing the timing of studies (year 
of research), the countries in which the studies were 
conducted and the type of consultation under scrutiny 
(eg, IBD nurse consultations, IBD specialist consulta-
tions, etc). Information will be extracted on research 
setting, participant characteristics including their role 
(eg, patient, parent, nurse, gastroenterologist, etc), socio-
demographics and the status of patient participants (eg, 
pregnant, preconception, postsurgery, in transition to 
adult care, etc), as well as disease characteristics including 
type of IBD (UC, CD or IBD unclassified), disease activity, 
disease phenotype and extraintestinal manifestations. 
Stated aims, aims relevant to the review (eg, investi-
gation of whether/how the clinicians talk about treat-
ment options including their benefits and side effects, 
patient’s quality of life or goals of care; description of 
clinician–patient relationship as construed in talk; etc), 
study design, health outcomes and measures and stated 
findings and conclusions will be described for each study. 
Information on the consultation data including the size of 
the dataset (corpus size), the actual number of consulta-
tion/episodes analysed in the study, the average length of 
consultations, whether consultations were audio recorded 
or video recorded and whether the consultations were 
one- off or in series will be charted. Furthermore, the 
method of linguistic data analysis and the investigated 
linguistic features will be described. A linguistic feature 
is broadly defined as any semantic, grammatical or lexical 
concept such as topic, question (type and quantity), 
length of consultation and so on.
Box 1 outlines the data items that will be included in 
the review. Additional items will potentially be added to 
this list based on the information available in the selected 
papers.
Outcomes and prioritisation
A description of the characteristics of conversations 
between clinicians who manage IBD and patients with 
IBD (and/or their parent/guardian) during a consulta-
tion is the main outcome of this review. These character-
istics generally identify the content of the consultation, 
patients’ and clinicians’ experience as represented in the 
consultation, the interpersonal relationships between 
clinician and patient, the different steps involved and the 
flow of information in the consultation. Another main 
outcome is an estimation of the effect of IBD clinical 
discussion on health outcomes (biomedical and psycho-
social). Secondary outcomes include a description of the 
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characteristics of the existing consultation data available 
for scrutiny in the literature, and trends in IBD clinical 
communication research including mainstream analytic 
approaches.
Risk of bias in individual studies
Conventional guidelines for assessing the quality of 
studies for inclusion in a systematic literature review18 
have limited application to discourse analytic research 
because this type of research is different from the main-
stream qualitative and quantitative health research in 
terms of its objective and methodology.15 Rather than 
using a single set of criteria and ranking studies based 
on those criteria, following Parry and Land, two broad 
dimensions will be used to assess each study’s value and 
contribution: (1) the type and amount of data, and (2) 
the credibility and reliability of the analysis.15 Credi-
bility is defined as ‘the confidence that can be placed 
in the truth of the research findings’19 (p121). To assess 
the credibility of the studies, Matthiessen’s account 
of the methodological approaches to the analysis of a 
situation type (eg, IBD consultation)20 will be used as a 
guide. Matthiessen’s methodological account20 is based 
on Halliday’s systemic functional linguistics.21 Gener-
ally, language consists of four layers or strata (context, 
semantics, grammar and lexis and phonology) and four 
main functions (experiential, logical, interpersonal and 
textual). Function of language equals ‘use’: what is it that 
the language is being used for? The four main functions 
(or metafunctions) of language occur simultaneously in 
any utterance or text.17 The experiential function allows 
language users to use language to construe their experi-
ence; the interpersonal function allows language users 
to enact their roles and relationships with each other 
(eg, status, intimacy, contact, sharedness between inter-
actants); the logical function concerns how language 
users create relations between different parts of their 
talk, and the textual function is what turns a collection 
of individual words into a coherent text.17 22 A compre-
hensive description of a situation type is time consuming 
and labour intensive. Matthiessen suggests principled 
selection of data and data analysis tools to reduce the 
description bias and increase credibility.20 To assess the 
reliability of the studies, information regarding the pres-
ence or absence of a second coder and the use of a unit 
of analysis will be considered.
Included studies will also be evaluated in terms of the 
amount of evidence used to support their conclusions 
and whether the conclusions were biassed or evidence 
based.23 Further quality assessment dimensions may be 
added depending on the included studies. Missing infor-
mation will not be sought from the authors, neither will 
unclear aspects of the studies be clarified with them. 
Rather, such limitations will be discussed under risk of 
bias.
Synthesis
The extracted data will be presented in overview tables 
for the purpose of summarisation and comparison and 
described in a narrative synthesis. The inclusion criteria 
in this review allow for including studies from a range of 
contexts such as IBD specialist consultations, nurse consul-
tations, allied health consultations, and general practice 
consultations. It is, therefore, expected that the context of 
the included studies will vary. It is also expected that these 
studies will be within different research traditions, having 
different underpinning philosophical assumptions, given 
the diverse approaches to the analysis of talk in health 
research, in general. Considering the diversity of contexts 
and theoretical underpinnings, a narrative synthesis was 
chosen as the method of synthesising data.
The narrative synthesis will be based on the results of 
the data extraction and quality appraisal. Furthermore, 
following the recommendations of Cochrane Consumers 
and Communication Review Group,24 the narrative 
synthesis will also include investigation of the similarities 
and the differences between the studies based on the 
study design and information gathered from the data 
extraction and quality appraisal. Since this is not a meta- 
synthesis, findings of the included studies will not be inte-
grated, and the data will not be reinterpreted.
Patient and public involvement
There has been no contribution from patients or the 
public to the design of this systematic review protocol.
Box 1 Data items included in the data extraction template
 ► Participant characteristics
Participants and numbers
Participant sociodemographics
Additional health status information
 ► Disease characteristics
Type of IBD
Disease activity
Disease phenotype
Extraintestinal manifestation
 ► Study characteristics
Year of research
Country of research
Research setting and type of consultation
Stated aims
Aims relevant to the review
Study design
Outcomes and measures
Stated findings
Stated conclusions
 ► Consultation data and analysis characteristics
Corpus size and number of consultations/episodes analysed in the 
study
Average length of consultations
One- off consultation or series
Data type (audio or video)
Method of linguistic data analysis (sociolinguistics, conversation 
analysis, content analysis, etc)
Linguistic component/s analysed
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Open access 
ETHICS AND DISSEMINATION
No human subject participants will be involved. There-
fore, ethical approval will not be required. Findings of 
this systematic review will be presented at national and 
international conferences and published in peer- reviewed 
journals (open access if possible). In the event of protocol 
amendments, the date of each amendment will be accom-
panied by a description of the change and the rationale.
DISCUSSION
Clinician–patient communication is shown to affect 
biological and functional health outcomes25–29 and 
can have economic consequences.30–32 In IBD, clinical 
communication is argued to affect patient satisfaction, 
treatment adherence, patient quality of life, disease 
management and self- management, as described in the 
Introduction section. This systematic review will be the 
first to review studies that examine clinical communi-
cation in IBD using recorded clinician–patient consul-
tation data. It aims to investigate the characteristics of 
IBD clinical discussions and the effects of these discus-
sions on health outcomes (biomedical and psychosocial). 
The current protocol outlines the steps and procedures 
involved in achieving this objective.
Collecting and reviewing evidence from studies that 
investigate recorded clinical communication in IBD for 
the first time, consulting a diverse range of databases 
to identify eligible studies, developing a broad search 
strategy to maximise inclusion and using a comprehen-
sive theory of language for appraising the quality of the 
included studies are arguably among the strengths of this 
review. Nevertheless, there are limitations as well. Reviews 
of this kind inevitably include a diverse range of studies in 
terms of context and theoretical underpinnings and this 
review will not be an exception. The consequence of this 
diversity is that findings cannot be integrated to produce 
cumulative evidence. For this reason, a narrative synthesis 
approach will be taken where data will be summarised 
and compared but not statistically integrated. In addi-
tion, because of funding limitations, this review will 
be restricted to publications in English language only 
and, thus, may not represent all the available evidence. 
Nevertheless, the results of the review can provide clini-
cians with valuable information to improve the way they 
communicate with their patients during a consultation. It 
will also identify the gaps in the literature and the areas 
that require further investigation for future research.
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